Predictions
Swedish Orphan Biovitrum Ab
Start price
Target price
Perf. (%)
€23.37
11.11.21
11.11.21
€28.00
11.11.22
11.11.22
-18.19%
12.11.22
12.11.22
Could be worthwhile Investment >10% per year
Zynga Inc.
Start price
Target price
Perf. (%)
€6.55
11.11.21
11.11.21
€7.80
11.11.22
11.11.22
-12.31%
27.11.21
27.11.21
Capable Management
Very low/no dividend yield expected
Risky balance sheet
Few uniques
Fuchs Petrolub SE VZO
Start price
Target price
Perf. (%)
€41.94
11.11.21
11.11.21
€45.00
11.11.22
11.11.22
-5.87%
03.01.22
03.01.22
Good culture
Medium risks for its business
Sustainability is important
Valneva SE ADR
Start price
Target price
Perf. (%)
€44.00
11.11.21
11.11.21
€48.00
11.11.22
11.11.22
-68.18%
12.11.22
12.11.22
Could be worthwhile Investment >10% per year
alstria office REIT-AG
Start price
Target price
Perf. (%)
€19.41
09.11.21
09.11.21
-
09.11.22
09.11.22
-12.67%
11.02.22
11.02.22
Probably not worthwhile Investment
Higher risks for its business
BMW AG VZO
Start price
Target price
Perf. (%)
€76.75
09.11.21
09.11.21
€86.00
09.11.22
09.11.22
-1.37%
10.11.22
10.11.22
High dividend yield expected
Revenue decline/stagnation expected
Below average Management
Little innovation
BioNTech SE ADR
Start price
Target price
Perf. (%)
€204.60
09.11.21
09.11.21
€260.00
09.11.22
09.11.22
-27.30%
30.01.22
30.01.22
Innovative
Some uniques
overvalued
Below average Management
ProSiebenSat.1 Media SE
Start price
Target price
Perf. (%)
€14.67
09.11.21
09.11.21
-
09.11.22
09.11.22
-47.42%
10.11.22
10.11.22
Fuchs Petrolub SE ST
Start price
Target price
Perf. (%)
€31.15
09.11.21
09.11.21
€10,050
-
12.11.21
12.11.21
Could be worthwhile Investment >10% per year
Known brand
Good culture
Invitae Corp
Start price
Target price
Perf. (%)
€20.09
09.11.21
09.11.21
€17.00
31.12.23
31.12.23
-23.92%
01.12.21
01.12.21
Could be very worthwhile Investment >20% year
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€9.23
09.11.21
09.11.21
€7.00
31.12.23
31.12.23
-56.18%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
TUI AG ADR
Start price
Target price
Perf. (%)
€1.40
08.11.21
08.11.21
€1.80
08.11.22
08.11.22
-15.71%
27.11.21
27.11.21
Revenue decline/stagnation expected
Increased challenges to pay loans and raise capital
Growths slower than the competition
Very high cyclical dependencies
BioNTech SE ADR
Start price
Target price
Perf. (%)
€196.95
08.11.21
08.11.21
-
08.11.22
08.11.22
6.63%
13.11.21
13.11.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
